Stress, Diurnal Cortisol, and Breast Cancer Survival

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

NCT06926530 ·Status: NOT_YET_RECRUITING

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

NCT01124695 ·Status: COMPLETED ·Phase: PHASE2

Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

NCT00764322 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

NCT00084396 ·Status: COMPLETED ·Phase: PHASE2

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

NCT00005605 ·Status: COMPLETED

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

NCT00110136 ·Status: TERMINATED ·Phase: PHASE2

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

NCT00569543 ·Status: COMPLETED

Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer

NCT00691509 ·Status: UNKNOWN

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

NCT00967239 ·Status: UNKNOWN

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

NCT00002646 ·Status: COMPLETED ·Phase: PHASE3

Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors

NCT03837496 ·Status: COMPLETED ·Phase: NA

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy

NCT00916162 ·Status: COMPLETED

Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer

NCT04693338 ·Status: COMPLETED ·Phase: PHASE1

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

NCT00053339 ·Status: WITHDRAWN ·Phase: PHASE3

Tamoxifen Citrate in Patients With Breast Cancer

NCT00963209 ·Status: UNKNOWN ·Phase: PHASE3

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

NCT03505736 ·Status: COMPLETED

Study of Breast Cancer Prevention by Letrozole in High Risk Women

NCT00579826 ·Status: COMPLETED ·Phase: PHASE2

Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

NCT00005079 ·Status: COMPLETED ·Phase: PHASE3

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

NCT01138553 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer

NCT00002762 ·Status: COMPLETED

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066690 ·Status: COMPLETED ·Phase: PHASE3

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

NCT00002580 ·Status: COMPLETED ·Phase: PHASE3

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

NCT01004744 ·Status: COMPLETED ·Phase: NA

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

NCT00659373 ·Status: COMPLETED ·Phase: PHASE3